# Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

> **NCT00004204** · PHASE2 · UNKNOWN · sponsor: **Herbert Irving Comprehensive Cancer Center**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00004204
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004204, "Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*